IXICO plc
PHYOF · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.02 | 0.03 | -0.45 |
| FCF Yield | -40.31% | -87.14% | -20.97% | -5.40% |
| EV / EBITDA | -0.64 | -0.54 | -6.05 | 13.12 |
| Quality | ||||
| ROIC | -14.43% | -23.10% | -10.52% | 1.54% |
| Gross Margin | 48.71% | 47.02% | 49.06% | 55.18% |
| Cash Conversion Ratio | 0.61 | 0.87 | -0.26 | 1.39 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.66% | -12.62% | -10.15% | -3.21% |
| Free Cash Flow Growth | 14.80% | -32.63% | -103.80% | 47.08% |
| Safety | ||||
| Net Debt / EBITDA | 1.66 | 0.76 | 5.15 | -7.00 |
| Interest Coverage | -159.63 | -86.16 | -49.55 | 3.36 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 97.74 | 130.17 | 42.51 | 102.72 |